Granules India gets USFDA nod for generic antidepressant drug

"We are pleased to receive approval of Bupropion Hydrochloride (XL) tablet product within first review cycle of 10 months from filing date. This product will be a valuable addition to our growing modified release product portfolio in the US market," GPI Executive Director Priyanka Chigurupati stated.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news